System and method for the development of cd30 bispecific antibodies for immunotherapy of cd30+ malignancies
US-2025346680-A1 · Nov 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Lum Lawrence G patents
Lum Lawrence G is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lum Lawrence G |
| Total patents | 20 |
| First publication | Jun 25, 2015 |
| Latest publication | Nov 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Bispecific antibodies
US-2025319127-A1 · Oct 16, 2025 · US
Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignancies
US-12391764-B2 · Aug 19, 2025 · US
Infusion of fresh immune effector cells armed with multispecific antibody
US-2024415890-A1 · Dec 19, 2024 · US
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
US-2024342213-A1 · Oct 17, 2024 · US
Recombinant PD-L1 peptides and methods of use
US-12006511-B2 · Jun 11, 2024 · US
Methods and compositions for cells expressing a chimeric intracellular signaling molecule
US-11890301-B2 · Feb 6, 2024 · US
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
US-2024026293-A1 · Jan 25, 2024 · US
System and method for the development of cd30 bispecific antibodies for immunotherapy of cd30+ malignancies
US-2023312738-A1 · Oct 5, 2023 · US
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies
US-11667721-B2 · Jun 6, 2023 · US
Recent patents
Latest publications not already listed above.
Methods and compositions for cells expressing a chimeric intracellular signaling molecule
US-11649435-B2 · May 16, 2023 · US
Recombinant PD-L1 Peptides and Methods of Use
US-2023135850-A1 · May 4, 2023 · US
Induction of highly efficacious anti-tumor and immune modulating activity: cell-free off the shelf therapeutic modality
US-2023043806-A1 · Feb 9, 2023 · US
Bispecific antibody targeting of t regulatory cells for treatment of inflammatory conditions
US-2022273718-A1 · Sep 1, 2022 · US
Priming with targeted activated t cells can enhance chemo responsiveness of cancer cells
US-2022175836-A1 · Jun 9, 2022 · US
System and method for the development of cd30 bispecific antibodies for immunotherapy of cd30+ malignancies
US-2020095330-A1 · Mar 26, 2020 · US
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
US-2018282693-A1 · Oct 4, 2018 · US
Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule
US-2018243341-A1 · Aug 30, 2018 · US
Polyclonal bispecific antibody compositions and method of use
US-9499619-B2 · Nov 22, 2016 · US
Polyclonal bispecific antibody compositions and method of use
US-2015175700-A1 · Jun 25, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Virginia Patent Foundation | 12 |
| Univ Wayne State | 9 |
| Univ Pennsylvania | 6 |
| Medical College Of Wisconsin Inc | 4 |
| Medical College Wisconsin Inc | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 18 |
| C07K16/2809 | 14 |
| A61K40/11 | 14 |
| A61K35/17 | 13 |
| A61P35/00 | 12 |